Roche Holding
Roche Holding is a Swiss healthcare and biotechnology company that designs and produces pharmaceuticals, diagnostic devices and research products. The company offers products for treating cancer, cardiovascular diseases, diabetes, obesity and more.
Date: To be determined
Hours of event: To be determined
Location: Kings Place, 90 York Way, London N1 9AG
Executives in attendance:
CEO: Yes
CFO: Yes
Head of IR: Yes
Division Managers: Yes
Others: Department heads of research and development
Who may attend: Money managers and sell-side analysts welcome
Number of attendees permitted: Open
Access: Open
Registration required? Yes
Simultaneous webcast? Yes
Composition of event:
Discussion of company’s financial performance/projections? Yes
Overview of strategic outlook? Yes
Tours of company facilities? No
Opportunities for Q&A with executives? Yes
Opportunities for one-on-one or small group meetings with key execs? No
What readers of Institutional Investor should know about your event:
We focused on the long-term value proposition of Roche and how we aim to facilitate innovation in the group. We focused on the sustainabiltity of cash flow and cash generation in the medium and long term rather than the short term (year) impacts.
For more information contact:
Dr. Karl Mahler, Head of Investor Relations
Karl.Mahler@roche.com
+41-61-687-8503
